137 related articles for article (PubMed ID: 35285354)
1. Cost of cancer management by stage at diagnosis among Medicare beneficiaries.
Reddy SR; Broder MS; Chang E; Paydar C; Chung KC; Kansal AR
Curr Med Res Opin; 2022 Aug; 38(8):1285-1294. PubMed ID: 35285354
[TBL] [Abstract][Full Text] [Related]
2. Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States.
McGarvey N; Gitlin M; Fadli E; Chung KC
J Med Econ; 2023; 26(1):1318-1329. PubMed ID: 37907436
[TBL] [Abstract][Full Text] [Related]
3. Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men.
Trogdon JG; Falchook AD; Basak R; Carpenter WR; Chen RC
JAMA Oncol; 2019 Jan; 5(1):60-66. PubMed ID: 30242397
[TBL] [Abstract][Full Text] [Related]
4. Trends and variations in utilization and costs of radiotherapy for prostate cancer: A SEER medicare analysis from 2007 through 2016.
Mukherjee K; Small W; Duszak R
Brachytherapy; 2022; 21(1):12-21. PubMed ID: 34380592
[TBL] [Abstract][Full Text] [Related]
5. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
[TBL] [Abstract][Full Text] [Related]
6. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.
Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD
Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193
[TBL] [Abstract][Full Text] [Related]
7. Healthcare utilization and cost burden of Huntington's disease among Medicare beneficiaries in the United States.
Exuzides A; Reddy SR; Chang E; Ta JT; Patel AM; Paydar C; Yohrling GJ
J Med Econ; 2021; 24(1):1327-1336. PubMed ID: 34730477
[TBL] [Abstract][Full Text] [Related]
8. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer.
Brown ML; Riley GF; Potosky AL; Etzioni RD
Med Care; 1999 Dec; 37(12):1249-59. PubMed ID: 10599606
[TBL] [Abstract][Full Text] [Related]
9. Unveiling SEER-CAHPS®: a new data resource for quality of care research.
Chawla N; Urato M; Ambs A; Schussler N; Hays RD; Clauser SB; Zaslavsky AM; Walsh K; Schwartz M; Halpern M; Gaillot S; Goldstein EH; Arora NK
J Gen Intern Med; 2015 May; 30(5):641-50. PubMed ID: 25586868
[TBL] [Abstract][Full Text] [Related]
10. Long-term cost of breast cancer treatment to the United States Medicare Program by stage at diagnosis.
Grady I; Grady S; Chanisheva N
Eur J Health Econ; 2021 Dec; 22(9):1365-1370. PubMed ID: 34008086
[TBL] [Abstract][Full Text] [Related]
11. Increased healthcare costs by later stage cancer diagnosis.
McGarvey N; Gitlin M; Fadli E; Chung KC
BMC Health Serv Res; 2022 Sep; 22(1):1155. PubMed ID: 36096813
[TBL] [Abstract][Full Text] [Related]
12. Disenrollment from Medicare managed care among beneficiaries with and without a cancer diagnosis.
Elkin EB; Ishill N; Riley GF; Bach PB; Gonen M; Begg CB; Schrag D
J Natl Cancer Inst; 2008 Jul; 100(14):1013-21. PubMed ID: 18612131
[TBL] [Abstract][Full Text] [Related]
13. Hospital Variation in Spending for Lung Cancer Resection in Medicare Beneficiaries.
Jean RA; Bongiovanni T; Soulos PR; Chiu AS; Herrin J; Kim N; Xu X; Kim AW; Gross CP
Ann Thorac Surg; 2019 Dec; 108(6):1710-1716. PubMed ID: 31400321
[TBL] [Abstract][Full Text] [Related]
14. Cancer stage at diagnosis and survival among persons with Social Security Disability Insurance on Medicare.
McCarthy EP; Ngo LH; Chirikos TN; Roetzheim RG; Li D; Drews RE; Iezzoni LI
Health Serv Res; 2007 Apr; 42(2):611-28. PubMed ID: 17362209
[TBL] [Abstract][Full Text] [Related]
15. The Cost of Metastatic Prostate Cancer in the United States.
Olsen TA; Filson CP; Richards TB; Ekwueme DU; Howard DH
Urol Pract; 2023 Jan; 10(1):41-47. PubMed ID: 37103444
[TBL] [Abstract][Full Text] [Related]
16. Projections of the cost of cancer care in the United States: 2010-2020.
Mariotto AB; Yabroff KR; Shao Y; Feuer EJ; Brown ML
J Natl Cancer Inst; 2011 Jan; 103(2):117-28. PubMed ID: 21228314
[TBL] [Abstract][Full Text] [Related]
17. Incremental Health Care Costs of Anxiety and Depression Among Medicare Beneficiaries With Cancer.
Birch K; Chung S; Zion SR; MacEwan JP; Malecki MJ
JCO Oncol Pract; 2023 May; 19(5):e660-e671. PubMed ID: 36800552
[TBL] [Abstract][Full Text] [Related]
18. Health care costs and utilization prior to diagnosis of antineutrophil cytoplasmic antibody vasculitis in Medicare beneficiaries.
Huang SP; Li X; Cao B; Nguyen JT; Robinson JE; Derebail VK; Hogan SL; Thorpe CT
J Manag Care Spec Pharm; 2022 Nov; 28(11):1292-1303. PubMed ID: 36282932
[No Abstract] [Full Text] [Related]
19. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
[TBL] [Abstract][Full Text] [Related]
20. Treatment and Survival of Medicare Beneficiaries with Colorectal Cancer: A Comparative Analysis Between a Rural State Cancer Registry and National Data.
Rane PB; Madhavan SS; Sambamoorthi U; Sita K; Kurian S; Pan X
Popul Health Manag; 2017 Feb; 20(1):55-65. PubMed ID: 27419662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
